Report cover image

2026 Global: Cardiac Ultrasound Systems Market -Competitive Review (2032) report

Publisher PerryHope Partners
Published Dec 15, 2025
Length 32 Pages
SKU # PHP20693750

Description

The 2026 Global: Cardiac Ultrasound Systems Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.

Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).

The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac ultrasound systems market by geography and historical trend. The scope of the report extends to sizing of the cardiac ultrasound systems market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.

The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?

The ten market players in this report and a brief synopsis of their participation in the market are:

GE HealthCare, Philips Healthcare, and Siemens Healthineers dominate the Cardiac Ultrasound Systems Market with substantial shares and innovative products. GE HealthCare leads with 20-25% market share, offering the Vivid Ultra Edition series featuring AI-enhanced imaging for precise cardiac diagnostics, launched in 2024. Philips Healthcare follows at 18-22%, introducing the EPIQ CVx system in 2025 with advanced quantification tools for accurate heart assessments and user-friendly interfaces. Siemens Healthineers holds 15-20%, releasing the ACUSON Sequoia with BioAcoustic imaging technology for superior tissue characterization in 2024. These companies emphasize AI integration, portability, and workflow efficiency, driving market growth projected from USD 2.01 billion in 2025 to USD 3.42 billion by 2032 at a 7.8% CAGR.

Canon Medical Systems, Hitachi Healthcare, and FUJIFILM Holdings rank prominently, focusing on imaging clarity and specialized cardiac applications. Canon commands 10-15% share, expanding the Aplio i-series with iBeam technology for exceptional image clarity and 3D/4D capabilities in 2025. Hitachi Healthcare, at 5-10%, developed the LISENDO 880 with real-time elastography for detailed cardiac tissue analysis in 2024. FUJIFILM Holdings provides versatile systems like the ALOKA ARIETTA 850, launched in 2024, alongside healthcare imaging solutions from its Tokyo base. Mindray Medical, a cost-effective leader from China, offers Resona and DC series with AI and cloud connectivity for accessible diagnostics. These firms prioritize affordability, reliability, and advanced features like elastography to meet diverse clinical needs.

Samsung Medison, Esaote SpA, and Analogic complete the top tier, emphasizing portability and niche innovations. Samsung delivers digital healthcare solutions including pediatric cardiac probes like TA2-9 in 2024, supporting point-of-care environments. Esaote SpA specializes in high-performance diagnostic ultrasound probes tailored for rigorous clinical demands since 1982. Analogic focuses on enabling technologies for CT and MRI-integrated ultrasound from its U.S. headquarters. Collectively, these ten—GE HealthCare, Philips, Siemens Healthineers, Canon, Hitachi, FUJIFILM, Mindray, Samsung, Esaote, and Analogic—control the market through R&D investments exceeding 6-10% of revenues, global footprints, and 2024-2025 launches enhancing AI, portability, and diagnostic precision amid rising cardiovascular demands.

Table of Contents

32 Pages
1.0 Scope of Report and Methodology
2.0 Market SWOT Analysis and Players
2.1 Market Definition
2.2 Market Segments
2.3 Market Strengths
2.4 Market Weaknesses
2.5 Market Threats
2.6 Market Opportunities
2.7 Major Players
3.0 Competitive Analysis
3.1 Market Player 1
3.2 Market Player 2
3.3 Market Player 3
3.4 Market Player 4
3.5 Market Player 5
3.6 Market Player 6
3.7 Market Player 7
3.8 Market Player 8
3.9 Market Player 9
3.10 Market Player 10
4.0 Comparative Business Strategies
4.1 Comparative Business Strategies of Player 1 and 2
4.2 Comparative Business Strategies of Player 1 and 3
4.3 Comparative Business Strategies of Player 1 and 4
4.4 Comparative Business Strategies of Player 2 and 3
4.5 Comparative Business Strategies of Player 2 and 4
4.6 Comparative Business Strategies of Player 3 and 4
5.0 Appendix

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.